Mental Health

Aussie biotech ENA Respiratory secures crucial US patents for its novel immune modulator, signaling a major strategic move in the multi-billion dollar fight against COPD.

A breakthrough publication identifies a novel protein, LanCL1, as a key target for neuropathic pain, validating a new class of drugs for millions of sufferers.

Sanofi's latest FDA nod for Tzield isn't just a new drug approval; it's a strategic shift from symptom management to disease modification in Type 1 Diabetes.

Top federal ministers, Canada's new CPHO, and the Fentanyl Czar will unveil updated opioid data and actions. Will it be enough to turn the tide on a crisis?

Healthcare Triangle secures $3.6M in complex convertible debt to fuel its AI ambitions. We unpack the high-stakes financing and what it means for the future.

A Solana memecoin raised nearly $100k for breast cancer prevention, revealing a potentially resilient new model for creating sustainable social impact.

MBX Biosciences' new one-year data for canvuparatide isn't just a clinical win; it's a calculated move to dominate a billion-dollar market left vacant.

A new survey shows Asians value independence over inheritance, yet a massive gap between intention and action threatens to derail their plans for self-reliance.

While firms spend billions on tech, a new book argues the biggest data breaches stem from leadership gaps and process failures. Is your boardroom the real front line?

A new FDA-designated device aims to filter a deadly protein from the blood of sepsis patients. Can this novel approach finally conquer a global health crisis?

Ottawa's new Safe Social Media Act imposes strict duties on tech giants to protect children, but raises critical questions about privacy and digital freedom.

As youth nicotine pouch use soars, Imperial Tobacco Canada calls for a crackdown on illicit sales. But is this a genuine public health plea or a masterful play to secure its market?

In memory of her daughter Elora, a mother's foundation joins a global research network, turning personal tragedy into a collaborative fight against a rare cancer.

Bill C-34 aims to shield kids from online harms, but health advocates see a bigger prize: curbing the digital marketing of unhealthy products.

The Chinese Canadian Museum's new 'Momentum' exhibition uses sports to explore power, identity, and the overlooked stories of legendary athletes.

Paradisus La Perla's new WITT certification isn't just an award; it's a strategic move by Meliá to capture the booming $1.3T wellness travel market.

A $4M grant for a Parkinson's drug isn't just charity; it's a strategic bet on a new era of medicine, where philanthropy acts as the catalyst for the next big cure.

Nancy Torres analyzes Héma-Québec's summer tour, revealing a sophisticated strategy to combat supply chain risks, secure plasma independence, and diversify its donor base.

As AI reshapes childhood with risks of addiction and anxiety, advocates argue that the oldest classroom—nature—is the most vital tool for building resilience.

One year in, the Facial Pain Registry has gathered data from 740 patients, creating an unprecedented resource to fight one of medicine's most misunderstood conditions.